Insulin aspart, recombinant Subcutaneous and Pentosan polysulfate sodium
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pentosan polysulfate sodium and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pentosan polysulfate sodium
Brand name: Elmiron
Synonyms: Pentosan Polysulfate Sodium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pentostatin
- Insulin aspart, recombinant Subcutaneous-Pentostatin Intravenous
- Insulin aspart, recombinant Subcutaneous-Pentothal
- Insulin aspart, recombinant Subcutaneous-Pentoxifylline
- Insulin aspart, recombinant Subcutaneous-Pentoxil
- Insulin aspart, recombinant Subcutaneous-Pepcid
- Pentosan polysulfate sodium-Insulin degludec
- Pentosan polysulfate sodium-Insulin Degludec (U-100) Prefilled Pens
- Pentosan polysulfate sodium-Insulin Degludec (U-100) Vials
- Pentosan polysulfate sodium-Insulin Degludec (U-200) Prefilled Pens
- Pentosan polysulfate sodium-Insulin degludec and liraglutide
- Pentosan polysulfate sodium-Insulin degludec and liraglutide Subcutaneous